A Fatal Case of Ciprofloxacin-induced Fulminant Hepatitis
- PMID: 32908821
- PMCID: PMC7473698
- DOI: 10.12890/2020_001612
A Fatal Case of Ciprofloxacin-induced Fulminant Hepatitis
Abstract
Fatal hepatotoxicity associated with ciprofloxacin is extremely rare. This is the second fully investigated case of fulminant hepatotoxicity due to ciprofloxacin in a male patient previously ciprofloxacin tolerant. The patient's medical history included stable Waldenstrom's macroglobulinaemia, inguinal hernia repair, prostate cancer (radiotherapy in 2006) and idiopathic Parkinson's disease. Extensive investigation for progressive liver failure confirmed drug-induced liver injury.
Learning points: Idiosyncratic drug-induced liver injury is rare, so a history of consumption of any potentially offending drug is vital.Exhaustive searches for alternative causes are imperative and a comprehensive history is essential, including a travel history with microbiological investigations if necessary; potential drug-induced liver injury must always be considered.The patient's age and past medical history may affect outcome.
Keywords: Ciprofloxacin; adverse drug reaction; hepatitis.
© EFIM 2020.
Conflict of interest statement
Conflicts of Interests: The Authors declare that there are no competing interests.
References
-
- Fuchs S, Simon Z, Brezis M. Fatal hepatic failure associated with ciprofloxacin. Lancet. 1994;343:738–739. - PubMed
-
- Van Bambeke F, Tulkens PM. Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. Drug Saf. 2009;32:359–378. - PubMed
-
- National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox. Available from www.livertox.nih.gov.
LinkOut - more resources
Full Text Sources
Miscellaneous